Syndax Pharmaceuticals Inc (SNDX)
Net Debt
$252.91M
Quarterly · Period ending: · USD
SNDX Net Debt
Latest reported$252.91Mperiod ending
Latest reported$252.91Mperiod ending
SNDX Quarterly Net Debt (-$537.00 → $252.91M)
Quarterly net debt
High-resolution chart · PNG
SNDX net debt history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Net Debt (USD) |
|---|---|
| 252,905,000 | |
| 214,467,000 | |
| 211,553,000 | |
| 228,623,000 | |
| -106,961,000 | |
| -152,156,000 | |
| 191,656,000 | |
| -132,165,000 | |
| -104,266,000 | |
| -113,227,000 | |
| -293,759,000 | |
| -92,680,000 | |
| -95,176,000 | |
| -56,458,000 | |
| -73,195,000 | |
| -70,120,000 | |
| -99,154,000 | |
| -167,752,000 | |
| -200,997,000 | |
| -49,788,000 | |
| -47,269,000 | |
| -43,616,000 | |
| -94,707,000 | |
| -35,805,000 | |
| -33,048,000 | |
| -24,051,000 | |
| -23,712,000 | |
| -29,578,000 | |
| -25,411,000 | |
| -56,761,000 | |
| -33,769,000 | |
| -26,705,000 | |
| -32,204,000 | |
| -27,981,000 | |
| -35,168,000 | |
| -20,732,000 | |
| -22,988,000 | |
| -22,356,000 | |
| -23,844,000 | |
| -12,753,000 | |
| -14,441,000 | |
| -23,187,000 | |
| -23,179,000 | |
| -46,039,000 | |
| 12,208,000 | |
| 3,875,000 | |
| -1,772,000 | |
| -4,680,000 | |
| -6,840,000 | |
| -10,104,000 | |
| -3,548,000 | |
| 628 | |
| -537 |